AU4480793A - Method for the safe administration of fatty acid - Google Patents

Method for the safe administration of fatty acid

Info

Publication number
AU4480793A
AU4480793A AU44807/93A AU4480793A AU4480793A AU 4480793 A AU4480793 A AU 4480793A AU 44807/93 A AU44807/93 A AU 44807/93A AU 4480793 A AU4480793 A AU 4480793A AU 4480793 A AU4480793 A AU 4480793A
Authority
AU
Australia
Prior art keywords
fatty acid
safe administration
administration
safe
fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44807/93A
Other versions
AU666961B2 (en
Inventor
David Frederick Horrobin
Catherine Anne Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929218065A external-priority patent/GB9218065D0/en
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Publication of AU4480793A publication Critical patent/AU4480793A/en
Application granted granted Critical
Publication of AU666961B2 publication Critical patent/AU666961B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU44807/93A 1992-08-25 1993-08-23 Method for the safe administration of fatty acid Ceased AU666961B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9218065 1992-08-25
GB929218065A GB9218065D0 (en) 1992-08-25 1992-08-25 Method for the safe administration of fatty acids and their lithium salts
GB929222655A GB9222655D0 (en) 1992-08-25 1992-10-28 Method for the safe administration of fatty acids and theirlithium salts
GB9222655 1992-10-28

Publications (2)

Publication Number Publication Date
AU4480793A true AU4480793A (en) 1994-03-03
AU666961B2 AU666961B2 (en) 1996-02-29

Family

ID=26301490

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44807/93A Ceased AU666961B2 (en) 1992-08-25 1993-08-23 Method for the safe administration of fatty acid

Country Status (7)

Country Link
EP (1) EP0585058A1 (en)
JP (1) JPH06157305A (en)
CN (1) CN1090776A (en)
AU (1) AU666961B2 (en)
CA (1) CA2104747A1 (en)
NO (1) NO933017L (en)
NZ (1) NZ248475A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0734723A4 (en) * 1993-12-29 2001-04-11 Kowa Tekuno Sachi Co Ltd Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
CA2446059C (en) * 2001-05-14 2010-03-23 Martek Biosciences Corporation Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
JP4423447B2 (en) * 2003-05-28 2010-03-03 エーザイ・アール・アンド・ディー・マネジメント株式会社 Osteoporosis preventive and therapeutic agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1194418A1 (en) * 1983-12-06 1985-11-30 Казанский Государственный Ордена Трудового Красного Знамени Медицинский Институт Им.С.В.Курашева Method of treatment of children having purulent destructive pneumonia
WO1992005797A1 (en) * 1990-10-05 1992-04-16 Shingo Nagamitu Chemico-inmunological antineoplastic preparation

Also Published As

Publication number Publication date
CA2104747A1 (en) 1994-02-26
NZ248475A (en) 1997-07-27
NO933017D0 (en) 1993-08-24
CN1090776A (en) 1994-08-17
AU666961B2 (en) 1996-02-29
EP0585058A1 (en) 1994-03-02
JPH06157305A (en) 1994-06-03
NO933017L (en) 1994-02-28

Similar Documents

Publication Publication Date Title
AU681569B3 (en) Process for the preparation of clavulanic acid
AU7672294A (en) Compositions and methods for the administration of delta-aminolevulinic acid
IL103817A0 (en) Method and intermediates for the preparation of prolineboronic acid esters
AU659456B2 (en) Fatty acid treatment
AU4801493A (en) New derivatives of neuraminic acid
ZA936233B (en) Method for the safe administration of fatty acids
AU4480693A (en) Method for the safe administration of fatty acid
AU3673293A (en) Process for the preparation of cinnamic acid derivatives
AU4480793A (en) Method for the safe administration of fatty acid
EP0560158A3 (en) Process for the preparation of beta-aminoacrylic acid esters
ZA936232B (en) Method for the safe administration of fatty acids
AU2181888A (en) Process for the preparation of 1-arylpyrazole-3-carboxylic acid esters
EP0538685A3 (en) Process for the preparation of vinyloxycarboxylic acid esters
AU4835893A (en) Process for the preparation of 5-formylpentane esters
GR861285B (en) Method for the preparation of 2-thiochromenyliden-acetoxic esters
GB9217713D0 (en) Method for the safe intravenous administration of fatty acids
GB9424595D0 (en) Process for the preparation of clavulanic acid
AU665159C (en) Process for the preparation of clavulanic acid
AU678752B3 (en) Process for the preparation of clavulanic acid
GB2272219B (en) Process for the preparation of isopropylidene-malonic esters
ZA946715B (en) Process for the preparation of clavulanic acid
GB9217712D0 (en) Method for the safe administration of fatty acids and their lithium salts
AU1598088A (en) Method for the preparation of amidino-urea derivatives
GB9325265D0 (en) Preparation of phenyloxoacetic acid derivatives
AU3784189A (en) Esters of 2,2-dimethyl-cyclopropane-carboxylic acid

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired